Charged particles in radiation oncology

Radiotherapy is one of the most common and effective therapies for cancer. Generally, patients are treated with X-rays produced by electron accelerators. Many years ago, researchers proposed that high-energy charged particles could be used for this purpose, owing to their physical and radiobiological advantages compared with X-rays. Particle therapy is an emerging technique in radiotherapy. Protons and carbon ions have been used for treating many different solid cancers, and several new centers with large accelerators are under construction. Debate continues on the cost:benefit ratio of this technique, that is, on whether the high costs of accelerators and beam delivery in particle therapy are justified by a clear clinical advantage. This Review considers the present clinical results in the field, and identifies and discusses the research questions that have resulted with this technique.

[1]  M. Krause,et al.  Exploring the role of cancer stem cells in radioresistance , 2008, Nature Reviews Cancer.

[2]  Yolande Lievens,et al.  Cost-effectiveness of particle therapy: current evidence and future needs. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  K. Flippo,et al.  Laser acceleration of quasi-monoenergetic MeV ion beams , 2006, Nature.

[4]  T. Teshima,et al.  Particle irradiation suppresses metastatic potential of cancer cells. , 2005, Cancer research.

[5]  G Kraft,et al.  Research needed for improving heavy-ion therapy , 2009 .

[6]  Marco Durante,et al.  Speed and accuracy of a beam tracking system for treatment of moving targets with scanned ion beams , 2009, Physics in medicine and biology.

[7]  I. Kaplan,et al.  Radiation Therapy , 2006 .

[8]  C. Lawton Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No , 2009 .

[9]  Keynote address—Adjuvant chemotherapy and cancer cure , 1982 .

[10]  Nobuyuki Kanematsu,et al.  Specification of Carbon Ion Dose at the National Institute of Radiological Sciences (NIRS). , 2007, Journal of radiation research.

[11]  Anders Brahme,et al.  Recent advances in light ion radiation therapy. , 2004, International journal of radiation oncology, biology, physics.

[12]  N. Keating,et al.  Comparative Analysis of Second Malignancy Risk in Patients Treated with Proton Therapy versus Conventional Photon Therapy , 2008 .

[13]  H. Tsujii,et al.  Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. , 2007, International journal of radiation oncology, biology, physics.

[14]  Torunn I Yock,et al.  Technology Insight: proton beam radiotherapy for treatment in pediatric brain tumors , 2004, Nature Clinical Practice Oncology.

[15]  J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[16]  E. Halperin Particle therapy and treatment of cancer. , 2006, The Lancet. Oncology.

[17]  G. Taucher‐Scholz,et al.  The impact of conventional and heavy ion irradiation on tumor cell migration in vitro , 2007, International journal of radiation biology.

[18]  P. Lambin,et al.  Particle therapy in lung cancer: where do we stand? , 2008, Cancer treatment reviews.

[19]  E. Hall The Impact of Protons on the Incidence of Second Malignancies in Radiotherapy , 2007, Technology in cancer research & treatment.

[20]  H. Tsujii,et al.  Clinical advantages of carbon-ion radiotherapy , 2008 .

[21]  André Wambersie,et al.  Comparison of the Methods of Specifying Carbon Ion Doses at NIRS and GSI. , 2007, Journal of radiation research.

[22]  E Pedroni,et al.  Experimental characterization and physical modelling of the dose distribution of scanned proton pencil beams , 2005, Physics in medicine and biology.

[23]  J. Debus,et al.  Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base , 2009, Cancer.

[24]  T. Teshima,et al.  Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. , 2003, Cancer research.

[25]  Hirohiko Tsujii,et al.  Particle radiation therapy using proton and heavier ion beams. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Christian P Karger,et al.  The future of heavy ion radiotherapy. , 2008, Medical physics.

[27]  N. Wiklund,et al.  Technology Insight: surgical robots—expensive toys or the future of urologic surgery? , 2004, Nature Clinical Practice Urology.

[28]  Riwa Kishimoto,et al.  Clinical Results of Carbon Ion Radiotherapy at NIRS. , 2007, Journal of radiation research.

[29]  William Speier,et al.  Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  C A Tobias,et al.  Radiological Physics Characteristics of the Extracted Heavy Ion Beams of the Bevatron , 1971, Science.

[31]  Oliver Jäkel,et al.  On the cost-effectiveness of Carbon ion radiation therapy for skull base chordoma. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  E. Rofstad,et al.  Increased Metastatic Dissemination in Human Melanoma Xenografts after Subcurative Radiation Treatment , 2004, Cancer Research.

[33]  B. Jones,et al.  The case for particle therapy. , 2006, The British journal of radiology.

[34]  F A Cucinotta,et al.  Karyotypes of Human Lymphocytes Exposed to High-Energy Iron Ions , 2002, Radiation research.

[35]  M Bues,et al.  Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. , 2004, International journal of radiation oncology, biology, physics.

[36]  Marco Durante,et al.  Cancer risk from exposure to galactic cosmic rays: implications for space exploration by human beings. , 2006, The Lancet. Oncology.

[37]  Katia Parodi,et al.  Comparison between in-beam and offline positron emission tomography imaging of proton and carbon ion therapeutic irradiation at synchrotron- and cyclotron-based facilities. , 2008, International journal of radiation oncology, biology, physics.

[38]  E. J. Ainsworth,et al.  Molecular and cellular radiobiology of heavy ions. , 1982, International journal of radiation oncology, biology, physics.

[39]  D. de Ruysscher,et al.  Current Clinical Evidence for Proton Therapy , 2009, Cancer journal.

[40]  H. Tsujii,et al.  Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience. , 2008, International journal of radiation oncology, biology, physics.

[41]  Irving L. Weissman,et al.  Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.

[42]  T S Lawrence,et al.  Recent advances in radiation oncology. , 1995, The New England journal of medicine.

[43]  M Scholz,et al.  RBE for carbon track-segment irradiation in cell lines of differing repair capacity. , 1999, International journal of radiation biology.

[44]  K. Mills,et al.  Heavy ion carcinogenesis and human space exploration , 2008 .

[45]  H. Kooy,et al.  Proton beam therapy , 2005, British Journal of Cancer.

[46]  Dirk De Ruysscher,et al.  Proton therapy in clinical practice: current clinical evidence. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  Michael Scholz,et al.  Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo. , 2008, International journal of radiation oncology, biology, physics.

[48]  Michael Scholz,et al.  Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. , 2007, International journal of radiation oncology, biology, physics.

[49]  Jean-Luc Balligand,et al.  Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. , 2003, Cancer research.

[50]  Harald Paganetti,et al.  Relative biological effectiveness (RBE) values for proton beam therapy. , 2002, International journal of radiation oncology, biology, physics.

[51]  N. Hamada Recent insights into the biological action of heavy-ion radiation. , 2009, Journal of radiation research.

[52]  E. Hall,et al.  Intensity-modulated radiation therapy, protons, and the risk of second cancers. , 2006, International journal of radiation oncology, biology, physics.

[53]  Jacques Bernier,et al.  Molecular therapy in head and neck oncology , 2009, Nature Reviews Clinical Oncology.

[54]  J. P. Morgan A patient's perspective on randomized clinical trials for proton radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  Masahiko Watanabe,et al.  Comparison of biological effectiveness of carbon-ion beams in Japan and Germany. , 2009, International journal of radiation oncology, biology, physics.

[56]  Susumu Kandatsu,et al.  Carbon Ion Radiotherapy for Stage I Non-small Cell Lung Cancer Using a Regimen of Four Fractions during 1 Week , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[57]  Alexei Vazquez,et al.  The genetics of the p53 pathway, apoptosis and cancer therapy , 2008, Nature Reviews Drug Discovery.

[58]  H. Paganetti The impact of protons on the incidence of second malignancies in radiotherapy by Eric J. Hall; Supp.31-34 2007. , 2007, Technology in cancer research & treatment.

[59]  Sairos Safai,et al.  Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[60]  D. Brenner,et al.  Secondary neutrons in clinical proton radiotherapy: a charged issue. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[61]  P. P. Reddy,et al.  Cytogenetic damage in lymphocytes of rubber industry workers. , 1986, Environmental research.

[62]  Carlo Greco,et al.  Current status of radiotherapy with proton and light ion beams , 2007, Cancer.

[63]  D. Nash,et al.  Initial clinical experience with BL-J433. , 1968, The Journal of clinical pharmacology and the journal of new drugs.

[64]  Y. Akino,et al.  Carbon-ion beam irradiation effectively suppresses migration and invasion of human non-small-cell lung cancer cells. , 2009, International journal of radiation oncology, biology, physics.

[65]  M. Durante,et al.  X-rays vs. carbon-ion tumor therapy: cytogenetic damage in lymphocytes. , 2000, International journal of radiation oncology, biology, physics.

[66]  R. Doll,et al.  Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[67]  H. Tsujii,et al.  Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer. , 2009, Lung cancer.